>
pdufa.bio

AB-101

Updated ยทnext FDA decision on the calendar

AB-101 is a Artiva Biotherapeutics, Inc. program. Its next catalyst is a Readout in Aug 2027. Every date links its source.

ARTV catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Artiva Biotherapeutics, Inc. (ARTV). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Aug 2027ARTV

Questions

When is AB-101's next FDA decision or readout?

The next tracked catalyst for AB-101 is a Readout in Aug 2027.

What happened at AB-101's most recent FDA decision?

No FDA decision for AB-101 is in our archive yet.

Who makes AB-101?

Artiva Biotherapeutics, Inc. (ARTV).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.